
Journal of Shanghai Jiao Tong University (Medical Science) ›› 2026, Vol. 46 ›› Issue (4): 502-508.doi: 10.3969/j.issn.1674-8115.2026.04.010
• Clinical research • Previous Articles
Received:2025-04-24
Accepted:2025-12-24
Online:2026-04-10
Published:2026-04-10
Contact:
Yu Jiwei
E-mail:jenniferyu919@126.com
CLC Number:
Jiang Shuang, Yu Jiwei. Clinical efficacy of intra-abdominal anastomosis in laparoscopic right hemicolectomy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2026, 46(4): 502-508.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2026.04.010
| 0 |
Tab 1 Comparison of baseline data between the two groups of patients after propensity score matching
| 0 |
| Variable | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Operative time/min | 183.41±19.85 | 180.22±16.01 | 0.447 |
| Intraoperative blood loss/mL | 79.01±7.15 | 92.88±15.43 | <0.001 |
| Access incision length/cm | 5.75±1.29 | 8.61±1.79 | <0.001 |
Tab 2 Comparison of intraoperative data between the two groups after propensity score matching
| Variable | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Operative time/min | 183.41±19.85 | 180.22±16.01 | 0.447 |
| Intraoperative blood loss/mL | 79.01±7.15 | 92.88±15.43 | <0.001 |
| Access incision length/cm | 5.75±1.29 | 8.61±1.79 | <0.001 |
| Variable | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Time to first flatus/d | 3.08±1.05 | 3.94±1.71 | 0.012 |
| Time to first defecation/d | 3.91±1.14 | 4.81±1.25 | 0.003 |
| Pain score/score | 3.09±1.32 | 5.66±1.23 | <0.001 |
| Postoperative hospital stay/d | 8.25±5.64 | 7.97±5.99 | 0.843 |
Tab 3 Comparison of postoperative recovery between the two groups after propensity score matching
| Variable | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Time to first flatus/d | 3.08±1.05 | 3.94±1.71 | 0.012 |
| Time to first defecation/d | 3.91±1.14 | 4.81±1.25 | 0.003 |
| Pain score/score | 3.09±1.32 | 5.66±1.23 | <0.001 |
| Postoperative hospital stay/d | 8.25±5.64 | 7.97±5.99 | 0.843 |
| Clavien-Dindo classification | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Overall complication | |||
| Grade Ⅰ | 3 (9.38) | 2 (6.25) | 0.500 |
| Grade Ⅱ | 3 (9.38) | 8 (25.00) | 0.042 |
| Grade Ⅲa | 1 (3.13) | 1 (3.13) | 1.000 |
| Grade Ⅲb | 0 (0) | 1 (3.13) | 1.000 |
| Grade Ⅳ | 0 (0) | 0 (0) | ‒ |
| Grade Ⅴ (death) | 0 (0) | 0 (0) | ‒ |
| Specific complication | |||
| Surgical site infection (overall) | 2 (6.25) | 9 (28.13) | 0.032 |
| Grade Ⅰ | 1 (3.13) | 1 (3.13) | |
| Grade Ⅱ | 1 (3.13) | 8 (25.00) | |
| Anastomotic leak (Grade Ⅲa) | 1 (3.13) | 1 (3.13) | 1.000 |
| Bleeding/hemorrhage (Grade Ⅱ/Ⅲb) | 1 (3.13) / 0 (0) | 1 (3.13) / 1 (3.13) | 0.500 |
Tab 4 Comparison of Clavien-Dindo classification of short-term complications between the two groups after propensity score matching [n(%)]
| Clavien-Dindo classification | IA group (n=32) | EA group (n=32) | P value |
|---|---|---|---|
| Overall complication | |||
| Grade Ⅰ | 3 (9.38) | 2 (6.25) | 0.500 |
| Grade Ⅱ | 3 (9.38) | 8 (25.00) | 0.042 |
| Grade Ⅲa | 1 (3.13) | 1 (3.13) | 1.000 |
| Grade Ⅲb | 0 (0) | 1 (3.13) | 1.000 |
| Grade Ⅳ | 0 (0) | 0 (0) | ‒ |
| Grade Ⅴ (death) | 0 (0) | 0 (0) | ‒ |
| Specific complication | |||
| Surgical site infection (overall) | 2 (6.25) | 9 (28.13) | 0.032 |
| Grade Ⅰ | 1 (3.13) | 1 (3.13) | |
| Grade Ⅱ | 1 (3.13) | 8 (25.00) | |
| Anastomotic leak (Grade Ⅲa) | 1 (3.13) | 1 (3.13) | 1.000 |
| Bleeding/hemorrhage (Grade Ⅱ/Ⅲb) | 1 (3.13) / 0 (0) | 1 (3.13) / 1 (3.13) | 0.500 |
| [1] | Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN[J]. Gut, 2023, 72(2): 338-344. |
| [2] | Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. |
| [3] | 陈茹,魏文强. 《2022年中国癌症发病和死亡报告》解读[J]. 中国实用外科杂志, 2025. 45(2): 174-180. |
| Chen R, Wei W Q. Interpretation of cancer incidence and mortality in China, 2022[J]. Chinese Journal of Practical Surgery,2025, 45(2): 174-180. | |
| [4] | Mukund K, Syulyukina N, Ramamoorthy S, et al. Right and left-sided colon cancers-specificity of molecular mechanisms in tumorigenesis and progression[J]. BMC Cancer, 2020, 20(1): 317. |
| [5] | Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nat Med, 2015, 21(11): 1350-1356. |
| [6] | Matsusaka S, Hanna D L, Cao S, et al. Prognostic impact of IL6 Genetic variants in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy[J]. Clin Cancer Res, 2016, 22(13): 3218-3226. |
| [7] | Boeckx N, Koukakis R, de Beeck K O, et al. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies[J]. Ann Oncol, 2017, 28(8): 1862-1868. |
| [8] | Barot S, Liljegren A, Nordenvall C, et al. Incidence trends and long-term survival in early-onset colorectal cancer: a nationwide Swedish study[J]. Ann Oncol, 2025, 36(11): 1400-1408. |
| [9] | Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial[J]. Lancet Oncol, 2009, 10(1): 44-52. |
| [10] | Lacy A M, García-Valdecasas J C, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial[J]. Lancet, 2002, 359(9325): 2224-2229. |
| [11] | Loungnarath R, Fleshman J W. Hand-assisted laparoscopic colectomy techniques[J]. Surg Innov, 2003, 10(4): 219-230. |
| [12] | Ripollés-Melchor J, Abad-Motos A, Zorrilla-Vaca A. Enhanced recovery after surgery (ERAS) in surgical oncology[J]. Curr Oncol Rep, 2022, 24(9): 1177-1187. |
| [13] | Trépanier M, Valin-Thorburn A, Kouyoumdjian A, et al. Intracorporeal versus extracorporeal anastomosis for right colectomy does not affect gastrointestinal recovery within an enhanced recovery after surgery program[J]. Surg Endosc, 2020, 34(10): 4601-4608. |
| [14] | Liao C K, Chern Y J, Lin Y C, et al. Short- and medium-term outcomes of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: a propensity score-matched study[J]. World J Surg Oncol, 2021, 19(1): 6. |
| [15] | Ferrer-Márquez M, Rubio-Gil F, Torres-Fernández R, et al. Intracorporeal versus extracorporeal anastomosis in patients undergoing laparoscopic right hemicolectomy: a multicenter randomized clinical trial (the IVEA-study)[J]. Surg Laparosc Endosc Percutan Tech, 2021, 31(4): 408-413. |
| [16] | Zizzo M, Zanelli M, Soriano A, et al. Comment on: randomized clinical trial of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy (IEA trial)[J]. Br J Surg, 2020, 107(7): e230. |
| [17] | Zheng J C, Zhao S, Chen W, et al. Comparison of intracorporeal and extracorporeal anastomosis and resection in right colectomy: a systematic review and meta-analysis[J]. Langenbecks Arch Surg, 2021, 406(6): 1789-1801. |
| [18] | Wei P Y, Li Y, Gao J L, et al. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: an updated systematic review and meta-analysis of randomized control trials[J]. Dig Surg, 2024, 41(5/6): 224-244. |
| [19] | Manigrasso M, Musella M, Elmore U, et al. Safety and efficacy of totally minimally invasive right colectomy in the obese patients: a multicenter propensity score-matched analysis[J]. Updates Surg, 2022, 74(4): 1281-1290. |
| [1] | Jiang Shuang, Yu Jiwei. Clinical efficacy of intra-abdominal anastomosis in laparoscopic right hemicolectomy [J]. Journal of Shanghai Jiao Tong University (Medical Science), 0, (): 1-7. |
| [2] | Jiang Shuang, Yu Jiwei. Clinical efficacy of intra-abdominal anastomosis in laparoscopic right hemicolectomy [J]. Journal of Shanghai Jiao Tong University (Medical Science), 0, (): 1-7. |
| [3] | SUN Ruizhuang, QIAO Kunpeng, LI Pu, XU Xiaolian, MENG Jun. Clinical value and transcriptional regulatory mechanism of ABCA7 in colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(11): 1490-1501. |
| [4] | LIANG Lebin, CHEN Huifang, LAI Shujing, GU liang, SU Bing. Analysis of epigenetic characteristics in colonic tumors of Apcmin/+via spatial ATAC-seq technology [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(10): 1261-1270. |
| [5] | JIANG Yi, HUANG Chenhao, LI Zhiliang, WU Junwei, ZHAO Ren, ZHANG Tao. Effect of preoperative chemotherapy combined with immunotherapy in a colorectal cancer patient with KRAS mutation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1256-1260. |
| [6] | XU Ling, HUANGFU Yuchan, SHEN Lisong, MA Yanhui. Causal association between plasma phosphatidylethanolamine and risk of colorectal adenocarcinoma: a two-sample Mendelian randomization study [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 605-613. |
| [7] | QIAN Liheng, WEN Kailing, LIAO Yingna, LI Shuxin, NIE Huizhen. Study on the effect and mechanism of sorting nexin 1 on inhibiting the proliferation and migration of colorectal cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1124-1135. |
| [8] | YU Yang, MENG Dan, QIU Yiwen, YUAN Jian, ZHU Yingjie. Analysis of impact of type 1 diabetes on colorectal cancer by using two-sample Mendelian randomization [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 755-761. |
| [9] | YU Yang, MENG Dan, QIU Yiwen, YUAN Jian, ZHU Yingjie. Analysis of impact of type 1 diabetes on colorectal cancer by using two-sample Mendelian randomization [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, (): 1-7. |
| [10] | XU Wenhui, YANG Chang, LI Ruiqing, BIAN Jing, LI Xiayi, ZHENG Leizhen. Exploratory study of interferon regulatory factor 3 promoting proliferation and invasion related to colorectal cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(3): 301-311. |
| [11] | WANG Anjun, LIU Ningning. Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(3): 320-332. |
| [12] | PENG Tian, XU Leiming. Crosstalk between epigenetic modification and circRNA in colorectal cancer: recent advances [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 237-243. |
| [13] | TU Juanjuan, JIN Zhiming. Research progress of immune checkpoint inhibitors in the treatment of metastatic colorectal cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 250-255. |
| [14] | HU Muni, JI Linhua, ZHANG Xinyu, SHEN Chaoqin, HONG Jie, CHEN Haoyan. Association analysis of T cell receptor repertoire diversity with clinical characteristics and Fusobacterium nucleatum abundance in colorectal cancer patients [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 1045-1052. |
| [15] | ZHAO Min, CHU Yimin, PENG Haixia. Research advances in screening modalities for colorectal cancer and colorectal adenoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 673-679. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
